Comparison of the 2007 and 2013 ASCO/CAP evaluation systems for HER2 amplification in breast cancer
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Pathology and Forensic Medicine
Reference38 articles.
1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int. J. Cancer,2010
2. Lapatinib plus capecitabine for HER2-positive advanced breast cancer;Geyer;N. Engl. J. Med.,2006
3. Cardiac toxicity of ErbB2-targeted therapies: what do we know?;Perez;Clin. Breast Cancer,2008
4. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N. Engl. J. Med.,2001
5. Lapatinib plus capecitabine for HER2-positive advanced-stage breast cancer in elderly women: review of the Anatolian Society of Medical Oncology (ASMO) experience;Cetin;Breast Care,2013
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinicopathologic features of breast cancer reclassified as HER2-amplified by fluorescence in situ hybridization with alternative chromosome 17 probes;Annals of Diagnostic Pathology;2020-10
2. The updated 2018 American Society of Clinical Oncology/College of American Pathologists guideline on human epidermal growth factor receptor 2 interpretation in breast cancer: comparison with previous guidelines and clinical significance of the proposed in situ hybridization groups;Human Pathology;2020-04
3. The Mediation Role of Psychological Hardiness between Emotional Self-regulation and Stress Management in Breast Cancer Patients;Journal of Pharmaceutical Research International;2019-11-07
4. Practical application of non-contact alternating current electric field mixing for reagent-saving in situ hybridisation of HER2;Journal of Clinical Pathology;2019-05-25
5. Impact of the 2018 ASCO/CAP HER2 guidelines update for HER2 testing by FISH in breast cancer;Pathology - Research and Practice;2019-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3